全体要約
感染症体外診断市場は、2022年の売上高5500万米ドルから2029年には7200万米ドルに成長すると予測されており、2023年から2029年の間に年平均成長率（CAGR）は4.0%と見込まれています。市場は、免疫測定、分子診断、微生物学などの製品タイプや、COVID-19、MRSA、結核などのアプリケーションに基づいてセグメント化されています。
主要な企業には、BD、BioMérieux SA、Abbott、Quidel Corporation、Hologic、Danaher、QIAGEN、Rocheなどが含まれ、2022年には上位2社が市場の大部分を占めています。地域別では、アメリカ、APAC、ヨーロッパ、中東・アフリカが含まれ、各地域での成長機会が分析されています。
関連する質問
5500万米ドル（2022年）
4.0%（2023年から2029年）
BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN, Roche, Siemens Healthineers AG, Bio-Rad Laboratories, Inc.
製品セグメンテーションの重要なトレンド, 企業の市場参入戦略, 地理的フットプリントの分析
概要
このインサイトレポートは、世界の感染症In-vitro診断の状況について包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。また、このレポートは、感染症In-vitro診断のポートフォリオと能力、市場参入戦略、市場ポジション、地理的な足跡に焦点を当てて、リーディンググローバル企業の戦略を分析し、加速するグローバル感染症In-vitro診断市場におけるこれらの企業の独自の位置をよりよく理解することを目的としています。
このインサイトレポートでは、感染症インビトロ診断の世界的な展望を形成する主要な市場動向、ドライバー、および影響要因を評価し、タイプ、アプリケーション、地理、そして市場規模別に予測を分解して、新たな機会のポケットを強調します。数百のボトムアップの定性的および定量的市場入力に基づく透明な方法論を用いて、この調査予測は世界の感染症インビトロ診断の現状と将来の軌道に関する非常に詳細な見解を提供します。
世界の感染症体外診断市場規模は、2022年の5500万米ドルから2029年の7200万米ドルに成長すると予測されています。2023年から2029年までの間に、年平均成長率（CAGR）は4.0%になる見込みです。
米国の感染症体外診断市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間でCAGRがXX%になると予測されています。
中国の感染症in-vitro診断市場は、2022年のXX米ドルから2029年のXX米ドルに増加すると推定されており、2023年から2029年までの期間でXX%のCAGRを記録する見込みです。
ヨーロッパの感染症体外診断市場は、2022年のXX米ドルから2029年にはXX米ドルに増加する見込みであり、2023年から2029年までの年平均成長率（CAGR）はXX%です。
グローバルな主要な感染症の体外診断プレーヤーには、BD、BioMérieux SA、Abbott、Quidel Corporation、OraSure Technologies, Inc.、Hologic, Inc. (Gen Probe)、Danaher、QIAGEN、Rocheなどが含まれます。収益の観点から、2022年には世界の2社がほぼXX%のシェアを占めました。
この報告書は、感染症体外診断市場の製品タイプ、アプリケーション、主要プレーヤー、主要地域および国別の包括的な概要、市場シェア、成長機会を提示しています。
市場セグメンテーション
タイプ別セグメンテーション
免疫測定法
分子診断
微生物学
その他
用途によるセグメンテーション
COVID-19
MRSA
クロストリジウム・ディフィシル
呼吸器ウイルス
結核および薬剤耐性結核
クラミジア
淋病
HPV
HIV
その他（消化管パネルテスト、C型肝炎、B型肝炎など）
この報告書は市場を地域別に分けています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から得た情報および企業のカバレッジ、製品ポートフォリオ、市場浸透の分析に基づいて選定されています。
BD
バイオメリュー SA
アボット
クイドル社
オラスレ Technologies, Inc.
ホロジック社（ジェンプローブ）
ダナハー
QIAGEN（キアゲン）
ロシュ
シーメンス・ヘルシニアーズAG
バイオラッドラボラトリーズ株式会社
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの感染症体外診断市場規模、（2018年～2029年）
2.1.2 感染症体外診断市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 感染症体外診断セグメント、タイプ別
2.2.1 イムノアッセイ
2.2.2 分子診断
2.2.3 微生物学
2.2.4 その他
2.3 感染症体外診断市場規模：タイプ別
2.3.1 感染症体外診断市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの感染症体外診断市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 感染症体外診断セグメント、用途別
2.4.1 COVID-19
2.4.2 メチシリン耐性黄色ブドウ球菌
2.4.3 クロストリジウム・ディフィシル
2.4.4 呼吸器ウイルス
2.4.5 結核と薬剤耐性結核
2.4.6 クラミジア
2.4.7 淋病
2.4.8 ヒトパピローマウイルス
2.4.9 HIV
2.4.10 その他（消化管パネル検査、C型肝炎、B型肝炎など）
2.5 感染症体外診断市場規模：用途別
2.5.1 感染症体外診断市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの感染症体外診断市場規模、市場シェア（用途別）（2018年～2023年）
3 感染症体外診断市場規模：プレイヤー別
3.1 感染症体外診断市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける感染症体外診断市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける感染症体外診断市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの感染症体外診断市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 感染症体外診断、地域別
4.1 感染症体外診断市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける感染症体外診断市場規模成長（2018年〜2023年）
4.3 APACにおける感染症体外診断市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける感染症体外診断市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける感染症体外診断市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける感染症体外診断市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける感染症体外診断市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける感染症体外診断市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける感染症体外診断市場規模、地域別（2018年〜2023年）
6.2 APACにおける感染症体外診断市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける感染症体外診断市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの感染症体外診断 国別（2018年～2023年）
7.2 ヨーロッパにおける感染症体外診断市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける感染症体外診断市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの感染症体外診断 地域別（2018年～2023年）
8.2 中東・アフリカにおける感染症体外診断市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける感染症体外診断市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの感染症体外診断市場、市場予測
10.1 グローバルの感染症体外診断、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの感染症体外診断、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの感染症体外診断、市場予測
10.1.3 APACの感染症体外診断、市場予測
10.1.4 ヨーロッパの感染症体外診断、市場予測
10.1.5 中東・アフリカの感染症体外診断、市場予測
10.2 アメリカズの感染症体外診断、市場予測（国別）（2024年～2029年）
10.3 APACの感染症体外診断、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの感染症体外診断、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの感染症体外診断、市場予測（地域別）（2024年～2029年）
10.6 グローバルの感染症体外診断、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの感染症体外診断、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 BD
11.1.1 BD：企業情報
11.1.2 BD：感染症体外診断分野の提供製品
11.1.3 BD：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 BD：主要事業概要
11.1.5 BD：直近の展開
11.2 BioMérieux SA
11.2.1 BioMérieux SA：企業情報
11.2.2 BioMérieux SA：感染症体外診断分野の提供製品
11.2.3 BioMérieux SA：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 BioMérieux SA：主要事業概要
11.2.5 BioMérieux SA：直近の展開
11.3 Abbott
11.3.1 Abbott：企業情報
11.3.2 Abbott：感染症体外診断分野の提供製品
11.3.3 Abbott：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Abbott：主要事業概要
11.3.5 Abbott：直近の展開
11.4 Quidel Corporation
11.4.1 Quidel Corporation：企業情報
11.4.2 Quidel Corporation：感染症体外診断分野の提供製品
11.4.3 Quidel Corporation：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Quidel Corporation：主要事業概要
11.4.5 Quidel Corporation：直近の展開
11.5 OraSure Technologies, Inc
11.6 Hologic, Inc\. \(Gen Probe\)
11.6.1 Hologic, Inc\. \(Gen Probe\)：企業情報
11.6.2 Hologic, Inc\. \(Gen Probe\)：感染症体外診断分野の提供製品
11.6.3 Hologic, Inc\. \(Gen Probe\)：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Hologic, Inc\. \(Gen Probe\)：主要事業概要
11.6.5 Hologic, Inc\. \(Gen Probe\)：直近の展開
11.7 Danaher
11.7.1 Danaher：企業情報
11.7.2 Danaher：感染症体外診断分野の提供製品
11.7.3 Danaher：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 Danaher：主要事業概要
11.7.5 Danaher：直近の展開
11.8 QIAGEN
11.8.1 QIAGEN：企業情報
11.8.2 QIAGEN：感染症体外診断分野の提供製品
11.8.3 QIAGEN：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 QIAGEN：主要事業概要
11.8.5 QIAGEN：直近の展開
11.9 Roche
11.9.1 Roche：企業情報
11.9.2 Roche：感染症体外診断分野の提供製品
11.9.3 Roche：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 Roche：主要事業概要
11.9.5 Roche：直近の展開
11.10 Siemens Healthineers AG
11.10.1 Siemens Healthineers AG：企業情報
11.10.2 Siemens Healthineers AG：感染症体外診断分野の提供製品
11.10.3 Siemens Healthineers AG：感染症体外診断収益・グロスマージンおよび市場シェア（2018年～2023年）
11.10.4 Siemens Healthineers AG：主要事業概要
11.10.5 Siemens Healthineers AG：直近の展開
11.11 Bio-Rad Laboratories, Inc
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Infectious Disease In-vitro Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease In-vitro Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease In-vitro Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease In-vitro Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease In-vitro Diagnostic.
The global Infectious Disease In-vitro Diagnostic market size is projected to grow from US$ 55 million in 2022 to US$ 72 million in 2029; it is expected to grow at a CAGR of 4.0% from 2023 to 2029.
United States market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Infectious Disease In-vitro Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Infectious Disease In-vitro Diagnostic players cover BD, BioMérieux SA, Abbott, Quidel Corporation, OraSure Technologies, Inc., Hologic, Inc. (Gen Probe), Danaher, QIAGEN and Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease In-vitro Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Immunoassay
Molecular Diagnostics
Microbiology
Others
Segmentation by application
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
BioMérieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Disease In-vitro Diagnostic Market Size 2018-2029
2.1.2 Infectious Disease In-vitro Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Infectious Disease In-vitro Diagnostic Segment by Type
2.2.1 Immunoassay
2.2.2 Molecular Diagnostics
2.2.3 Microbiology
2.2.4 Others
2.3 Infectious Disease In-vitro Diagnostic Market Size by Type
2.3.1 Infectious Disease In-vitro Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023)
2.4 Infectious Disease In-vitro Diagnostic Segment by Application
2.4.1 COVID-19
2.4.2 MRSA
2.4.3 Clostridium Difficile
2.4.4 Respiratory Virus
2.4.5 TB and Drug-resistant TB
2.4.6 Chlamydia
2.4.7 Gonorrhea
2.4.8 HPV
2.4.9 HIV
2.4.10 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
2.5 Infectious Disease In-vitro Diagnostic Market Size by Application
2.5.1 Infectious Disease In-vitro Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023)
3 Infectious Disease In-vitro Diagnostic Market Size by Player
3.1 Infectious Disease In-vitro Diagnostic Market Size Market Share by Players
3.1.1 Global Infectious Disease In-vitro Diagnostic Revenue by Players (2018-2023)
3.1.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Infectious Disease In-vitro Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Disease In-vitro Diagnostic by Regions
4.1 Infectious Disease In-vitro Diagnostic Market Size by Regions (2018-2023)
4.2 Americas Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
4.3 APAC Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
4.4 Europe Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
4.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Growth (2018-2023)
5 Americas
5.1 Americas Infectious Disease In-vitro Diagnostic Market Size by Country (2018-2023)
5.2 Americas Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
5.3 Americas Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease In-vitro Diagnostic Market Size by Region (2018-2023)
6.2 APAC Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
6.3 APAC Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Disease In-vitro Diagnostic by Country (2018-2023)
7.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Disease In-vitro Diagnostic by Region (2018-2023)
8.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023)
8.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Infectious Disease In-vitro Diagnostic Market Forecast
10.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2024-2029)
10.1.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2024-2029)
10.1.2 Americas Infectious Disease In-vitro Diagnostic Forecast
10.1.3 APAC Infectious Disease In-vitro Diagnostic Forecast
10.1.4 Europe Infectious Disease In-vitro Diagnostic Forecast
10.1.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast
10.2 Americas Infectious Disease In-vitro Diagnostic Forecast by Country (2024-2029)
10.2.1 United States Infectious Disease In-vitro Diagnostic Market Forecast
10.2.2 Canada Infectious Disease In-vitro Diagnostic Market Forecast
10.2.3 Mexico Infectious Disease In-vitro Diagnostic Market Forecast
10.2.4 Brazil Infectious Disease In-vitro Diagnostic Market Forecast
10.3 APAC Infectious Disease In-vitro Diagnostic Forecast by Region (2024-2029)
10.3.1 China Infectious Disease In-vitro Diagnostic Market Forecast
10.3.2 Japan Infectious Disease In-vitro Diagnostic Market Forecast
10.3.3 Korea Infectious Disease In-vitro Diagnostic Market Forecast
10.3.4 Southeast Asia Infectious Disease In-vitro Diagnostic Market Forecast
10.3.5 India Infectious Disease In-vitro Diagnostic Market Forecast
10.3.6 Australia Infectious Disease In-vitro Diagnostic Market Forecast
10.4 Europe Infectious Disease In-vitro Diagnostic Forecast by Country (2024-2029)
10.4.1 Germany Infectious Disease In-vitro Diagnostic Market Forecast
10.4.2 France Infectious Disease In-vitro Diagnostic Market Forecast
10.4.3 UK Infectious Disease In-vitro Diagnostic Market Forecast
10.4.4 Italy Infectious Disease In-vitro Diagnostic Market Forecast
10.4.5 Russia Infectious Disease In-vitro Diagnostic Market Forecast
10.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast by Region (2024-2029)
10.5.1 Egypt Infectious Disease In-vitro Diagnostic Market Forecast
10.5.2 South Africa Infectious Disease In-vitro Diagnostic Market Forecast
10.5.3 Israel Infectious Disease In-vitro Diagnostic Market Forecast
10.5.4 Turkey Infectious Disease In-vitro Diagnostic Market Forecast
10.5.5 GCC Countries Infectious Disease In-vitro Diagnostic Market Forecast
10.6 Global Infectious Disease In-vitro Diagnostic Forecast by Type (2024-2029)
10.7 Global Infectious Disease In-vitro Diagnostic Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Infectious Disease In-vitro Diagnostic Product Offered
11.1.3 BD Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 BioMérieux SA
11.2.1 BioMérieux SA Company Information
11.2.2 BioMérieux SA Infectious Disease In-vitro Diagnostic Product Offered
11.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BioMérieux SA Main Business Overview
11.2.5 BioMérieux SA Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Infectious Disease In-vitro Diagnostic Product Offered
11.3.3 Abbott Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Quidel Corporation
11.4.1 Quidel Corporation Company Information
11.4.2 Quidel Corporation Infectious Disease In-vitro Diagnostic Product Offered
11.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Quidel Corporation Main Business Overview
11.4.5 Quidel Corporation Latest Developments
11.5 OraSure Technologies, Inc.
11.5.1 OraSure Technologies, Inc. Company Information
11.5.2 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Offered
11.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 OraSure Technologies, Inc. Main Business Overview
11.5.5 OraSure Technologies, Inc. Latest Developments
11.6 Hologic, Inc. (Gen Probe)
11.6.1 Hologic, Inc. (Gen Probe) Company Information
11.6.2 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Offered
11.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Hologic, Inc. (Gen Probe) Main Business Overview
11.6.5 Hologic, Inc. (Gen Probe) Latest Developments
11.7 Danaher
11.7.1 Danaher Company Information
11.7.2 Danaher Infectious Disease In-vitro Diagnostic Product Offered
11.7.3 Danaher Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Danaher Main Business Overview
11.7.5 Danaher Latest Developments
11.8 QIAGEN
11.8.1 QIAGEN Company Information
11.8.2 QIAGEN Infectious Disease In-vitro Diagnostic Product Offered
11.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 QIAGEN Main Business Overview
11.8.5 QIAGEN Latest Developments
11.9 Roche
11.9.1 Roche Company Information
11.9.2 Roche Infectious Disease In-vitro Diagnostic Product Offered
11.9.3 Roche Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Roche Main Business Overview
11.9.5 Roche Latest Developments
11.10 Siemens Healthineers AG
11.10.1 Siemens Healthineers AG Company Information
11.10.2 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Offered
11.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Siemens Healthineers AG Main Business Overview
11.10.5 Siemens Healthineers AG Latest Developments
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Bio-Rad Laboratories, Inc. Company Information
11.11.2 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Offered
11.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.11.5 Bio-Rad Laboratories, Inc. Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Infectious Disease In-vitro Diagnostic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Immunoassay Table 3. Major Players of Molecular Diagnostics Table 4. Major Players of Microbiology Table 5. Major Players of Others Table 6. Infectious Disease In-vitro Diagnostic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 7. Global Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023) & ($ Millions) Table 8. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023) Table 9. Infectious Disease In-vitro Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 10. Global Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023) & ($ Millions) Table 11. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023) Table 12. Global Infectious Disease In-vitro Diagnostic Revenue by Players (2018-2023) & ($ Millions) Table 13. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Player (2018-2023) Table 14. Infectious Disease In-vitro Diagnostic Key Players Head office and Products Offered Table 15. Infectious Disease In-vitro Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Infectious Disease In-vitro Diagnostic Market Size by Regions 2018-2023 & ($ Millions) Table 19. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Regions (2018-2023) Table 20. Global Infectious Disease In-vitro Diagnostic Revenue by Country/Region (2018-2023) & ($ millions) Table 21. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Country/Region (2018-2023) Table 22. Americas Infectious Disease In-vitro Diagnostic Market Size by Country (2018-2023) & ($ Millions) Table 23. Americas Infectious Disease In-vitro Diagnostic Market Size Market Share by Country (2018-2023) Table 24. Americas Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023) & ($ Millions) Table 25. Americas Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023) Table 26. Americas Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023) & ($ Millions) Table 27. Americas Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023) Table 28. APAC Infectious Disease In-vitro Diagnostic Market Size by Region (2018-2023) & ($ Millions) Table 29. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Region (2018-2023) Table 30. APAC Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023) & ($ Millions) Table 31. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023) Table 32. APAC Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023) & ($ Millions) Table 33. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023) Table 34. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2018-2023) & ($ Millions) Table 35. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Country (2018-2023) Table 36. Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023) & ($ Millions) Table 37. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023) Table 38. Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023) & ($ Millions) Table 39. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023) Table 40. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Region (2018-2023) & ($ Millions) Table 41. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Region (2018-2023) Table 42. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2018-2023) & ($ Millions) Table 43. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023) Table 44. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2018-2023) & ($ Millions) Table 45. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023) Table 46. Key Market Drivers & Growth Opportunities of Infectious Disease In-vitro Diagnostic Table 47. Key Market Challenges & Risks of Infectious Disease In-vitro Diagnostic Table 48. Key Industry Trends of Infectious Disease In-vitro Diagnostic Table 49. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 50. Global Infectious Disease In-vitro Diagnostic Market Size Market Share Forecast by Regions (2024-2029) Table 51. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Type (2024-2029) & ($ Millions) Table 52. Global Infectious Disease In-vitro Diagnostic Market Size Forecast by Application (2024-2029) & ($ Millions) Table 53. BD Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 54. BD Infectious Disease In-vitro Diagnostic Product Offered Table 55. BD Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 56. BD Main Business Table 57. BD Latest Developments Table 58. BioMérieux SA Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 59. BioMérieux SA Infectious Disease In-vitro Diagnostic Product Offered Table 60. BioMérieux SA Main Business Table 61. BioMérieux SA Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 62. BioMérieux SA Latest Developments Table 63. Abbott Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 64. Abbott Infectious Disease In-vitro Diagnostic Product Offered Table 65. Abbott Main Business Table 66. Abbott Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 67. Abbott Latest Developments Table 68. Quidel Corporation Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 69. Quidel Corporation Infectious Disease In-vitro Diagnostic Product Offered Table 70. Quidel Corporation Main Business Table 71. Quidel Corporation Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 72. Quidel Corporation Latest Developments Table 73. OraSure Technologies, Inc. Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 74. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product Offered Table 75. OraSure Technologies, Inc. Main Business Table 76. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 77. OraSure Technologies, Inc. Latest Developments Table 78. Hologic, Inc. (Gen Probe) Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 79. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product Offered Table 80. Hologic, Inc. (Gen Probe) Main Business Table 81. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 82. Hologic, Inc. (Gen Probe) Latest Developments Table 83. Danaher Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 84. Danaher Infectious Disease In-vitro Diagnostic Product Offered Table 85. Danaher Main Business Table 86. Danaher Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 87. Danaher Latest Developments Table 88. QIAGEN Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 89. QIAGEN Infectious Disease In-vitro Diagnostic Product Offered Table 90. QIAGEN Main Business Table 91. QIAGEN Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 92. QIAGEN Latest Developments Table 93. Roche Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 94. Roche Infectious Disease In-vitro Diagnostic Product Offered Table 95. Roche Main Business Table 96. Roche Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 97. Roche Latest Developments Table 98. Siemens Healthineers AG Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 99. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product Offered Table 100. Siemens Healthineers AG Main Business Table 101. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 102. Siemens Healthineers AG Latest Developments Table 103. Bio-Rad Laboratories, Inc. Details, Company Type, Infectious Disease In-vitro Diagnostic Area Served and Its Competitors Table 104. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product Offered Table 105. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 106. Bio-Rad Laboratories, Inc. Main Business Table 107. Bio-Rad Laboratories, Inc. Latest Developments List of Figures Figure 1. Infectious Disease In-vitro Diagnostic Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Infectious Disease In-vitro Diagnostic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Infectious Disease In-vitro Diagnostic Sales Market Share by Country/Region (2022) Figure 8. Infectious Disease In-vitro Diagnostic Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type in 2022 Figure 10. Infectious Disease In-vitro Diagnostic in COVID-19 Figure 11. Global Infectious Disease In-vitro Diagnostic Market: COVID-19 (2018-2023) & ($ Millions) Figure 12. Infectious Disease In-vitro Diagnostic in MRSA Figure 13. Global Infectious Disease In-vitro Diagnostic Market: MRSA (2018-2023) & ($ Millions) Figure 14. Infectious Disease In-vitro Diagnostic in Clostridium Difficile Figure 15. Global Infectious Disease In-vitro Diagnostic Market: Clostridium Difficile (2018-2023) & ($ Millions) Figure 16. Infectious Disease In-vitro Diagnostic in Respiratory Virus Figure 17. Global Infectious Disease In-vitro Diagnostic Market: Respiratory Virus (2018-2023) & ($ Millions) Figure 18. Infectious Disease In-vitro Diagnostic in TB and Drug-resistant TB Figure 19. Global Infectious Disease In-vitro Diagnostic Market: TB and Drug-resistant TB (2018-2023) & ($ Millions) Figure 20. Infectious Disease In-vitro Diagnostic in Chlamydia Figure 21. Global Infectious Disease In-vitro Diagnostic Market: Chlamydia (2018-2023) & ($ Millions) Figure 22. Infectious Disease In-vitro Diagnostic in Gonorrhea Figure 23. Global Infectious Disease In-vitro Diagnostic Market: Gonorrhea (2018-2023) & ($ Millions) Figure 24. Infectious Disease In-vitro Diagnostic in HPV Figure 25. Global Infectious Disease In-vitro Diagnostic Market: HPV (2018-2023) & ($ Millions) Figure 26. Infectious Disease In-vitro Diagnostic in HIV Figure 27. Global Infectious Disease In-vitro Diagnostic Market: HIV (2018-2023) & ($ Millions) Figure 28. Infectious Disease In-vitro Diagnostic in Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc) Figure 29. Global Infectious Disease In-vitro Diagnostic Market: Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc) (2018-2023) & ($ Millions) Figure 30. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application in 2022 Figure 31. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Player in 2022 Figure 32. Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Regions (2018-2023) Figure 33. Americas Infectious Disease In-vitro Diagnostic Market Size 2018-2023 ($ Millions) Figure 34. APAC Infectious Disease In-vitro Diagnostic Market Size 2018-2023 ($ Millions) Figure 35. Europe Infectious Disease In-vitro Diagnostic Market Size 2018-2023 ($ Millions) Figure 36. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size 2018-2023 ($ Millions) Figure 37. Americas Infectious Disease In-vitro Diagnostic Value Market Share by Country in 2022 Figure 38. United States Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 39. Canada Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 40. Mexico Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 41. Brazil Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 42. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Region in 2022 Figure 43. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Type in 2022 Figure 44. APAC Infectious Disease In-vitro Diagnostic Market Size Market Share by Application in 2022 Figure 45. China Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 46. Japan Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 47. Korea Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 48. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 49. India Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 50. Australia Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 51. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Country in 2022 Figure 52. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023) Figure 53. Europe Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023) Figure 54. Germany Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 55. France Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 56. UK Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 57. Italy Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 58. Russia Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 59. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Region (2018-2023) Figure 60. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2018-2023) Figure 61. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2018-2023) Figure 62. Egypt Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 63. South Africa Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 64. Israel Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 65. Turkey Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 66. GCC Country Infectious Disease In-vitro Diagnostic Market Size Growth 2018-2023 ($ Millions) Figure 67. Americas Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 68. APAC Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 69. Europe Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 70. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 71. United States Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 72. Canada Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 73. Mexico Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 74. Brazil Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 75. China Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 76. Japan Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 77. Korea Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 78. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 79. India Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 80. Australia Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 81. Germany Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 82. France Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 83. UK Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 84. Italy Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 85. Russia Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 86. Spain Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 87. Egypt Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 88. South Africa Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 89. Israel Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 90. Turkey Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 91. GCC Countries Infectious Disease In-vitro Diagnostic Market Size 2024-2029 ($ Millions) Figure 92. Global Infectious Disease In-vitro Diagnostic Market Size Market Share Forecast by Type (2024-2029) Figure 93. Global Infectious Disease In-vitro Diagnostic Market Size Market Share Forecast by Application (2024-2029)
